PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
Clinical trial NCT03983876 · COMPLETED
Trial details
- NCT number
- NCT03983876
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2019-12-03
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.